Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and sapropterin

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with sapropterin in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(sapropterin)
Trials
(sapropterin)
Recent Studies (post-2010) (sapropterin)
9,1561875522,36293614

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caplan, MS; De Plaen, IG; Hsueh, W; Qu, XW; Rozenfeld, RA; Thaete, LG; Zhu, Y1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and sapropterin

ArticleYear
Tetrahydrobiopterin prevents platelet-activating factor-induced intestinal hypoperfusion and necrosis: Role of neuronal nitric oxide synthase.
    Critical care medicine, 2005, Volume: 33, Issue:5

    Topics: Animals; Antioxidants; Biopterins; Enzyme Inhibitors; Indazoles; Intestinal Diseases; Male; Nerve Tissue Proteins; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Platelet Activating Factor; Pterins; Rats; Rats, Sprague-Dawley; Splanchnic Circulation

2005